D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with …

A Poudel, Y Poudel, A Adhikari, BB Aryal, D Dangol… - Plos one, 2021 - journals.plos.org
Introduction Coronavirus Disease 2019 is a primarily respiratory illness that can cause
thrombotic disorders. Elevation of D-dimer is a potential biomarker for poor prognosis in …

D‐dimer, CRP, PCT, and IL‐6 Levels at Admission to ICU Can Predict In‐Hospital Mortality in Patients with COVID‐19 Pneumonia

M Milenkovic, A Hadzibegovic, M Kovac… - Oxidative medicine …, 2022 - Wiley Online Library
Introduction. Health care workers have had a challenging task since the COVID‐19
outbreak. Prompt and effective predictors of clinical outcomes are crucial to recognize …

A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients

R Giossi, D Menichelli, A Pani, E Tratta… - Frontiers in …, 2021 - frontiersin.org
Background: Antithrombotic treatment, including low molecular weight heparin (LMWH) or
unfractionated heparin (UFH), has been proposed as a potential therapy for coronavirus …

[HTML][HTML] Remdesivir efficacy in COVID-19 treatment: a randomized controlled trial

S Abd-Elsalam, M Salama, S Soliman… - … American Journal of …, 2021 - pmc.ncbi.nlm.nih.gov
To date, no antiviral therapy has shown proven clinical effectiveness in treating patients with
COVID-19. We assessed the efficacy of remdesivir in hospitalized Egyptian patients with …

The effects of vitamin C on the multiple pathophysiological stages of COVID-19

JR Miranda-Massari, AP Toro, D Loh, JR Rodriguez… - Life, 2021 - mdpi.com
Currently available anti-viral drugs may be useful in reducing the viral load but are not
providing the necessary physiological effects to reduce the SARS-CoV-2 complications …

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

CLK Rebelatto, AC Senegaglia, CL Franck… - Stem cell research & …, 2022 - Springer
Background COVID-19 is a multisystem disease that presents acute and persistent
symptoms, the postacute sequelae (PASC). Long-term symptoms may be due to …

Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborative

MH Gul, ZM Htun, V de Jesus Perez, M Suleman… - Respiratory …, 2023 - Springer
Objectives To investigate whether COVID-19 patients with pulmonary embolism had higher
mortality and assess the utility of d-dimer in predicting acute pulmonary embolism. Patients …

Artificial intelligence and discrete-event simulation for capacity management of intensive care units during the Covid-19 pandemic: a case study

M Ortiz-Barrios, S Arias-Fonseca, A Ishizaka… - Journal of business …, 2023 - Elsevier
The Covid-19 pandemic has pushed the Intensive Care Units (ICUs) into significant
operational disruptions. The rapid evolution of this disease, the bed capacity constraints, the …

Hematological, inflammatory, coagulation, and oxidative/antioxidant biomarkers as predictors for severity and mortality in COVID-19: a prospective cohort-study

SW Smail, E Babaei, K Amin - International Journal of General …, 2023 - Taylor & Francis
Purpose Oxidative stress (OS) and inflammation are pivotal points in the pathophysiology of
coronavirus disease-2019 (COVID-19). This study aims to use routine laboratory and …

Role of D-Dimer in assessing severity, monitoring, and predicating outcome in COVID-19 pneumonia: A single center study

S Patil, S Khule, S Toshniwal - Global Journal of Health Sciences and …, 2023 - gjhsr.org
Objectives: Robust data are available regarding role of D-dimer in analyzing coagulation
status in pulmonary embolisms and deep vein thrombosis. As thrombogenic nature of …